136 related articles for article (PubMed ID: 708027)
1. In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.
Smith TF; Washton HE
Antimicrob Agents Chemother; 1978 Sep; 14(3):493-4. PubMed ID: 708027
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Bowie WR; Shaw CE; Chan DG; Black WA
Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
Cevenini R; Sambri V; La Placa M
Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
[No Abstract] [Full Text] [Related]
4. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
[TBL] [Abstract][Full Text] [Related]
5. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.
Kuo CC; Wang SP; Grayston JT
Antimicrob Agents Chemother; 1977 Jul; 12(1):80-3. PubMed ID: 883821
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
8. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
Sambri V; Rumpianesi F; Franchi L; Cevenini R
G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
[No Abstract] [Full Text] [Related]
9. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
Johannisson G; Sernryd A; Lycke E
Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of rosaramicin against Chlamydia trachomatis.
Bowie WR
Antimicrob Agents Chemother; 1980 Dec; 18(6):978-9. PubMed ID: 7235684
[TBL] [Abstract][Full Text] [Related]
12. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Shadomy S; Tipple M; Paxton L
Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Santoro J; Kaye D; Levison ME
Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
DiPersio JR; Krafczyk TL
Antimicrob Agents Chemother; 1978 Aug; 14(2):274-6. PubMed ID: 697353
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Miyashita N; Matsumoto A; Matsushima T
Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
Stamm WE; Suchland R
Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
[TBL] [Abstract][Full Text] [Related]
20. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
Kwok YY; Sutter VL; Oberhammer I; Finegold SM
J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
